Edition:
United Kingdom

Achieve Life Sciences Inc (ACHV.OQ)

ACHV.OQ on NASDAQ Stock Exchange Capital Market

1.51USD
20 Feb 2018
Change (% chg)

$0.09 (+6.69%)
Prev Close
$1.42
Open
$2.12
Day's High
$2.19
Day's Low
$1.51
Volume
796,433
Avg. Vol
68,952
52-wk High
$7.15
52-wk Low
$1.15

Select another date:

Thu, Nov 9 2017

BRIEF-Achieve qtrly loss per share $0.90‍​

* Achieve Life Sciences Inc qtrly loss per share $0.90‍​ Source text for Eikon: Further company coverage:

BRIEF-Achieve Life Sciences entered into exclusive supply agreement with Sopharma AD

* Achieve Life Sciences -‍ co entered into exclusive supply agreement with Sopharma AD for manufacture of Cytisine API and finished tablets​

BRIEF-ACHIEVE LIFE SCIENCES COMMENCES ADVANCEMENT OF CYTISINE CLINICAL DEVELOPMENT PROGRAM

* ACHIEVE LIFE SCIENCES INC - ANNOUNCES COMMENCEMENT OF A MULTI-DOSE STUDY TO EVALUATE BOTH PK AND PD CHARACTERISTICS OF CYTISINE

BRIEF-Achieve announces share purchase agreement with Lincoln Park Capital Fund

* Achieve announces share purchase agreement with Lincoln Park Capital Fund LLC

Select another date: